Evolution of the clinical management of hypertension: Emerging role of “specific” vasodilators as initial therapy
- 1 January 1987
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 82 (1) , 36-43
- https://doi.org/10.1016/0002-9343(87)90142-2
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Adrenergic effects on plasma lipoprotein metabolism: Speculation on mechanisms of actionThe American Journal of Medicine, 1986
- Antihypertensive therapy and lipids: Paradoxical influences on cardiovascular disease riskThe American Journal of Medicine, 1986
- Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)Journal Of Hypertension, 1985
- MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2The Lancet, 1985
- Effects of prazosin on serum lipids in patients with essential hypertension: A review of the findings presented at the satellite symposium on coronary heart disease: Hypertension and other risk factors, Milan, 1983The American Journal of Cardiology, 1984
- Negative effects of diuretic drugs on metabolic risk factors for coronary heart disease: Possible alternative drug therapiesThe American Journal of Cardiology, 1983
- Multiple Risk Factor Intervention TrialJAMA, 1982
- Five-Year Findings of the Hypertension Detection and Follow-up ProgramPublished by American Medical Association (AMA) ,1979
- Effects Morbidity of Treatment on in HypertensionJAMA, 1970
- Surgery's Relevance to an Understanding of Basic BiologyPublished by American Medical Association (AMA) ,1967